Ticlopidine hydrochloride (Apotex Corp.)
Welcome to the PulseAid listing for the Ticlopidine hydrochloride drug offered from Apotex Corp.. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Apotex Corp. |
NON-PROPRIETARY NAME: | Ticlopidine hydrochloride |
SUBSTANCE NAME: | TICLOPIDINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1999-07-01 |
END MARKETING DATE: | 0000-00-00 |
Ticlopidine hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Ticlopidine hydrochloride from Apotex Corp. |
LABELER NAME: | Apotex Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 1999-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60505-0027_072b86f7-4a22-d3b2-ca03-8edd6bc1c128 |
PRODUCT NDC: | 60505-0027 |
APPLICATION NUMBER: | ANDA075089 |
Other TICLOPIDINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: